Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07106281

Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial

Effect of Chronic Grape Extract Supplementation in Trained Cross-training Athletes: A Randomized, Triple-blinded, Placebo-Controlled Crossover Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Universidad de Granada · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the effect of cronic GSE intake in crosstraining may have a favorable impact on biochemical markers, recovery, and performance.

Detailed description

Supplementation with certain antioxidant nutrients is a feasible strategy to accelerate recovery from fatigue and prevent exercise-induced oxidative damage. Grape seed extract (GSE) contains flavonoids such as proanthocyanidins, which are potent antioxidants with numerous health benefits. Therefore, optimizing the recovery process after training is essential for athletes engaged in strength and power sports who aim to enhance performance. Thirty trained CrossFit athletes consumed grape seed extract or a placebo for one week. The training session consisted of a 12-minute strength block, a 13-minute metabolic conditioning (MetCon), and a final 15-minute MetCon. The Rating of Perceived Exertion (RPE), Gastrointestinal Distress Score (GDS), blood pressure and the Perceived Recovery Status scale (RPS) were administered at the beginning of the session and at the end of each segment of the CrossFit session. DOMS was assessed using a visual analog scale at 24 and 48 hours after the CrossFit session.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGrape Seed Extract600mg of Grape Seed Extract
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2025-09-01
Primary completion
2025-12-20
Completion
2026-01-31
First posted
2025-08-06
Last updated
2025-08-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07106281. Inclusion in this directory is not an endorsement.